3 million Australian resident short-term departures in 2009, it is important that Australians traveling to malaria-endemic areas are prescribed malaria chemoprophylaxis, where appropriate. The aim of this study was to investigate the trends in use of antimalarial drugs, particularly those prescribed
for malaria prophylaxis in Australia, from 2005 to 2009. In 2011, data were extracted from the Australian Statistics on Medicines reports published by the Pharmaceutical Benefits Advisory Committee, Drug Utilization Committee, on antimalarials used in Australia for the period 2005 to 2009.[15-19] During 2005 see more to 2009, 12 drugs/drug combinations could have potentially been prescribed for malaria. Six drugs (chloroquine, primaquine, mefloquine, proguanil, atovaquone/proguanil, and artemether/lumefantrine) were most likely, almost solely used as antimalarials. The remaining six drugs (hydroxychloroquine, quinine bisulfate, quinine sulfate, pyrimethamine, pyrimethamine/sulfadoxine, and doxycycline) had additional indications. The former
group of drugs would be expected to be an accurate indicator of trends in antimalarial use, while the latter group would be a less accurate indicator of trends as other uses potentially confound prescriptions for antimalarial use. Data were obtained on the number of prescriptions for each of these antimalarials. Trends in use were descriptively analyzed.
Isotretinoin Afatinib ic50 Among the drugs solely used as antimalarial drugs from 2005 to 2009, atovaquone plus proguanil and melfloquine are now the most commonly prescribed antimalarials (Table 1). Mefloquine prescriptions had increased by 38% from 2005 to 2008, but then dropped 17% from 2008 to 2009. The numbers of prescriptions for atovaquone plus proguanil have trebled (306%). Prescriptions for proguanil have dropped over 90% from 2005 to 2009. The diaminopyrimidines, pyrimethamine-containing antimalarials, have mostly been removed from the prescription drug list. Prescriptions for chloroquine have reduced by 66% from 2005 to 2008 and chloroquine was only available on special access from 2009. Artemether plus lumefantrine combination had been used in relatively small quantities and was available only on special authority from 2007 to 2009. Quinine prescriptions have also fallen by 60% from 2005 to 2009. Although a considerable quantity of doxycycline has been prescribed, it was unknown how much was intended for malaria chemoprophylaxis. Trends in the use of antimalarial drugs for treatment and chemoprophylaxis have been found to be greatly influenced by availability of antimalarials, prevailing guidelines, and other factors, in several countries;[12, 13, 20, 21] however, this study was not designed to investigate factors that might impact on these trends.